28/11/2017 |
Bioequivalence of Digoxin |
CIDEM |
Registered |
03/11/2017 |
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
CIM |
Registered |
17/10/2017 |
Bioequivalence of Clopidogrel |
CIDEM |
Registered |
16/10/2017 |
Chitosan Unguent in burned patients |
CIDEM |
Registered |
13/10/2017 |
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) |
FINLAY |
Registered outdated |
04/10/2017 |
Bioequivalence of diclofenac sodium retard |
CIDEM |
Registered |
29/09/2017 |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
CENSA |
Registered |
27/09/2017 |
Bioequivalence of Abacavir |
CIDEM |
Registered |
05/09/2017 |
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma |
CIM |
Registered |
15/08/2017 |
Bioactive formulation to treat osteoarthritis |
SSA |
Registered |
15/08/2017 |
Homeostec for chronic arthritis |
SSA |
Registered |
15/08/2017 |
Phenamate in the treatment of prostate cancer |
SSA |
Registered |
14/08/2017 |
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |
BIOCEN |
Registered outdated |
30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered outdated |
30/04/2017 |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
CIM |
Registered |
30/04/2017 |
HEBERBIOVAC HB vaccine to reference material. |
CIGB |
Registered |
28/04/2017 |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
FINLAY |
Registered outdated |
27/04/2017 |
Hepatotoxicity by drugs |
CenQfal |
Registered |
17/02/2017 |
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
CIM |
Registered |
17/02/2017 |
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |